The LDN Books
We would like to thank all the authors for their time and support with The LDN Books, as well as the staff at Chelsea Green Publishing. Generously, all royalties will be given to the LDN Research Trust.
Low Dose Naltrexone (LDN) holds the potential to help millions of people suffering from various autoimmune diseases and cancers, and even those with autism, chronic fatigue, and depression find relief. Administered off-label in small daily doses (0.5 to 4.5 mg), this generic drug is extremely affordable and presents few known side effects. So why has it languished in relative medical obscurity?
The LDN Book Volume One
Compiled by Linda Elsegood of The LDN Research Trust—the world’s largest LDN charity organization with over 19,000 members worldwide—the book features ten chapters contributed by medical professionals on LDN’s efficacy and two patient-friendly appendices.
The LDN Book is a comprehensive resource for doctors, pharmacists, and patients who want to learn more about how LDN is helping people now, and a clarion call for further research that could help millions more.
The LDN Book Volume Two
The Latest Research on How Low Dose Naltrexone Could Revolutionize Treatment for PTSD, Pain, IBD, Lyme Disease, Dermatologic Conditions, and More.
The LDN Book Volume Three
The LDN Book, Volume 3 is both a resource for practitioners, pharmacists and patients and a renewed call for further research on the healing potential of this generic drug.
The Latest Research on: Viral Infections, Long COVID, Mold Toxicity, Longevity, Cancer, Depression and More.
Written by Medical Professionals, learn how Low Dose Naltrexone (LDN) can help with COVID and prolonged COVID, viruses, mold, CIRS, disease, cancer and more.